Multi-Chem Limited (SGX:AWZ)
Singapore · Delayed Price · Currency is SGD 4.010
+0.210 (5.53%)
Aug 12, 2026, 2:35 PM SGT
Multi-Chem Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 653.93 | 683.68 | 658.42 | 616.98 | 603.64 | |
Revenue Growth | -4.35% | 3.84% | 6.72% | 2.21% | 25.83% |
Cost of Revenue | 564.29 | 586.21 | 563.63 | 529.97 | 518.13 |
Gross Profit | 89.64 | 97.48 | 94.79 | 87.01 | 85.51 |
Selling, General & Admin | 62.05 | 63.55 | 62.2 | 64.35 | 54.77 |
Operating Expenses | 62.23 | 64.46 | 62.66 | 64.12 | 54.22 |
Operating Income | 27.41 | 33.02 | 32.14 | 22.89 | 31.29 |
Interest Expense | -3.63 | -1.57 | -0.84 | -0.46 | -0.33 |
Interest & Investment Income | 6.47 | 4.7 | 2.73 | 1.02 | 0.6 |
Currency Exchange Gain (Loss) | 0.69 | 0.22 | 0.16 | - | 1.48 |
Other Non Operating Income (Expenses) | 1.82 | 1.94 | 1.91 | 1.46 | 0.9 |
EBT Excluding Unusual Items | 32.76 | 38.31 | 36.09 | 24.91 | 33.94 |
Gain (Loss) on Sale of Investments | 0.14 | 0.15 | 0.15 | 0.16 | 0.13 |
Gain (Loss) on Sale of Assets | 0.06 | 0.37 | - | 0.16 | 0.24 |
Asset Writedown | -0.01 | - | - | - | - |
Other Unusual Items | 0.01 | - | 0.29 | 0.38 | 1.55 |
Pretax Income | 32.97 | 38.82 | 36.53 | 25.6 | 35.95 |
Income Tax Expense | 6.53 | 8 | 9.41 | 5.6 | 8.62 |
Earnings From Continuing Operations | 26.44 | 30.82 | 27.12 | 20 | 27.33 |
Minority Interest in Earnings | - | - | - | - | -2.38 |
Net Income | 26.44 | 30.82 | 27.12 | 20 | 24.96 |
Net Income to Common | 26.44 | 30.82 | 27.12 | 20 | 24.96 |
Net Income Growth | -14.21% | 13.62% | 35.63% | -19.88% | 40.41% |
Shares Outstanding (Basic) | 90 | 90 | 90 | 90 | 90 |
Shares Outstanding (Diluted) | 90 | 90 | 90 | 90 | 90 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 0.29 | 0.34 | 0.30 | 0.22 | 0.28 |
EPS (Diluted) | 0.29 | 0.34 | 0.30 | 0.22 | 0.28 |
EPS Growth | -14.21% | 13.64% | 35.61% | -19.88% | 40.41% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 45.42 | 36.12 | 24.84 | 11.27 | 26.21 |
Free Cash Flow Per Share | 0.50 | 0.40 | 0.28 | 0.13 | 0.29 |
Dividend Per Share | 0.311 | 0.253 | 0.243 | 0.177 | 0.111 |
Dividend Growth | 22.93% | 4.12% | 37.29% | 59.46% | 68.18% |
Gross Margin | 13.71% | 14.26% | 14.40% | 14.10% | 14.17% |
Operating Margin | 4.19% | 4.83% | 4.88% | 3.71% | 5.18% |
Profit Margin | 4.04% | 4.51% | 4.12% | 3.24% | 4.13% |
Free Cash Flow Margin | 6.94% | 5.28% | 3.77% | 1.83% | 4.34% |
EBITDA | 28.14 | 33.9 | 33.3 | 24.22 | 32.6 |
EBITDA Margin | 4.30% | 4.96% | 5.06% | 3.92% | 5.40% |
D&A For EBITDA | 0.73 | 0.88 | 1.16 | 1.32 | 1.31 |
EBIT | 27.41 | 33.02 | 32.14 | 22.89 | 31.29 |
EBIT Margin | 4.19% | 4.83% | 4.88% | 3.71% | 5.18% |
Effective Tax Rate | 19.80% | 20.61% | 25.75% | 21.88% | 23.97% |